Literature DB >> 11558891

Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.

J A Manjón-Haces, F Vázquez-López, S Gómez-Díez, A Hidalgo-García, R Pérez-Alvarez, T Soler-Sánchez, N Pérez-Oliva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11558891     DOI： 10.1080/000155501750376447

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

1.  [Drug-induced exanthema caused by pegylated interferon-alpha 2b].

Authors:  S Meller; A Erhardt; A Auci; N J Neumann; B Homey
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].

Authors:  D Bruch-Gerharz; J Reifenberger
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

Review 3.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

4.  Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis.

Authors:  Alessandro Federico; Dolores Sgambato; Gaetano Cotticelli; Antonietta Gerarda Gravina; Marcello Dallio; Filippo Beneduce; Eleonora Ruocco; Marco Romano; Carmela Loguercio
Journal:  Hepat Mon       Date:  2014-03-11       Impact factor: 0.660
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.